Antirheumatic drug treatment during pregnancy and lactation.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D001379:Azathioprine / Q000627:therapeutic use; D002738:Chloroquine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000032:analysis; D005260:Female; D005333:Fetus / Q000187:drug effects; D005865:Gestational Age; D006046:Gold / Q000008:administration & dosage; D006801:Humans; D007231:Infant, Newborn; D007774:Lactation / Q000187:drug effects*; D007978:Levamisole / Q000009:adverse effects; D008895:Milk, Human / Q000032:analysis; D010396:Penicillamine / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D007978:Levamisole; D006046:Gold; D002738:Chloroquine; D003520:Cyclophosphamide; D010396:Penicillamine; D001379:Azathioprine